Cargando…

Management of chemotherapy dose intensity for metastatic colorectal cancer

Chemotherapy dose intensity is a momentous parameter of antitumor clinical medication. In certain clinical trials, the actual application dose of the chemotherapeutic drugs is frequently different from the prescribed dose. The chemotherapy dose intensity completed in different trials is also variabl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chu, Xuelei, Xue, Peng, Zhu, Shijie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8931773/ https://www.ncbi.nlm.nih.gov/pubmed/35340557 http://dx.doi.org/10.3892/ol.2022.13261

Ejemplares similares

Use of perioperative chemotherapy in colorectal cancer metastatic to the liver
por: Symonds, Lynn K, et al.
Publicado: (2019)

Dose intensity in cancer chemotherapy.
por: Dodwell, D. J., et al.
Publicado: (1990)

Evaluating the recent developments in palliative chemotherapy for metastatic colorectal cancer
por: Baek, Sun Kyung, et al.
Publicado: (2019)

Factors influencing choice of chemotherapy in metastatic colorectal cancer (mCRC)
por: Rossi, Luigi, et al.
Publicado: (2013)

Chemotherapy and Targeted Agents in the Treatment of Elderly Patients with Metastatic Colorectal Cancer
por: Tuca, Albert, et al.
Publicado: (2020)

Impact of relative dose intensity in gemcitabine–cisplatin chemotherapy for metastatic urothelial carcinoma
por: Kohei, Naoki, et al.
Publicado: (2018)

Impact of G-CSF Prophylaxis on Chemotherapy Dose-Intensity, Link Between Dose-Intensity and Survival in Patients with Metastatic Pancreatic Adenocarcinoma
por: Canton, Clémence, et al.
Publicado: (2022)

Colorectal Cancer: Prevention and Management of Metastatic Disease
por: Sugarbaker, Paul H.
Publicado: (2014)

Colorectal cancer genomic biomarkers in the clinical management of patients with metastatic colorectal carcinoma
por: Rachiglio, Anna Maria, et al.
Publicado: (2020)

Correction to: Impact of G-CSF Prophylaxis on Chemotherapy Dose-Intensity, Link Between Dose-Intensity and Survival in Patients with Metastatic Pancreatic Adenocarcinoma
Publicado: (2022)

Prolonged survival in metastatic colorectal cancer following chemotherapy
por: Paul, Doru, et al.
Publicado: (2014)

Molecular subtypes and the evolution of treatment management in metastatic colorectal cancer
por: Martini, Giulia, et al.
Publicado: (2020)

Efficacy and safety of dose-dense chemotherapy in urothelial carcinoma
por: Zhu, Chenjing, et al.
Publicado: (2017)

Costs and consequences of different chemotherapy regimens in metastatic colorectal cancer
por: Hale, J P, et al.
Publicado: (2002)

Oxaliplatin- or irinotecan-based chemotherapy for metastatic colorectal cancer in the elderly
por: Aparicio, T, et al.
Publicado: (2003)

Oxaliplatin- or irinotecan-based chemotherapy for metastatic colorectal cancer in the elderly
por: Alliot, C, et al.
Publicado: (2004)

Comparative Effectiveness of Chemotherapy in Elderly Patients with Metastatic Colorectal Cancer
por: Satram-Hoang, Sacha, et al.
Publicado: (2012)

Chemotherapy options in elderly and frail patients with metastatic colorectal cancer
por: Saif, Muhammad Wasif
Publicado: (2012)

Popliteal pseudoaneurysm after FOLFOX chemotherapy for metastatic colorectal cancer
por: Cosic, Luka, et al.
Publicado: (2019)

Survival and relative dose intensity of 5-fluorouracil, oxaliplatin and irinotecan in real-life treatment of metastatic colorectal cancer
por: Blazevic, Ilfad, et al.
Publicado: (2020)

High-dose chemotherapy of metastatic breast cancer: the end of the beginning?
por: Crown, J.
Publicado: (1997)

Reduced Dose Intensity FOLFOX-4 as First Line Palliative Chemotherapy in Elderly Patients with Advanced Colorectal Cancer
por: Kim, Jee Hyun, et al.
Publicado: (2005)

Current challenges in the implementation of precision oncology for the management of metastatic colorectal cancer
por: Kim, Sun Young, et al.
Publicado: (2020)

The Role of Percutaneous Ablation in the Management of Colorectal Cancer Liver Metastatic Disease
por: Filippiadis, Dimitrios K., et al.
Publicado: (2021)

BRAF testing in metastatic colorectal carcinoma and novel, chemotherapy-free therapeutic options
por: Hummel, Michael, et al.
Publicado: (2021)

Systematic Review on Infusion Reactions Associated with Chemotherapies and Monoclonal Antibodies for Metastatic Colorectal Cancer
por: Song, Xue, et al.
Publicado: (2011)

Hepatic arterial chemotherapy for metastatic colorectal carcinoma.
por: de Takats, P. G., et al.
Publicado: (1994)

The cardiotoxicity of cetuximab as single therapy in Chinese chemotherapy-refractory metastatic colorectal cancer patients
por: Tang, Xue-Miao, et al.
Publicado: (2017)

Bioinformatics analysis of mRNA and miRNA microarray to identify the key miRNA-gene pairs in small-cell lung cancer
por: Mao, Yun, et al.
Publicado: (2019)

Phase II trial of dose-dense chemotherapy followed by dose-intense erlotinib for patients with newly diagnosed metastatic non-small cell lung cancer
por: PETTY, W. JEFFREY, et al.
Publicado: (2013)

Effectiveness and Safety of Intensive Triplet Chemotherapy Plus Bevacizumab, FIr-B/FOx, in Young-Elderly Metastatic Colorectal Cancer Patients
por: Bruera, Gemma, et al.
Publicado: (2013)

Reply: Oxaliplatin- or irinotecan-based chemotherapy for metastatic colorectal cancer in the elderly
por: Aparicio, T, et al.
Publicado: (2004)

Molecular markers of response and toxicity to FOLFOX chemotherapy in metastatic colorectal cancer
por: Chua, W, et al.
Publicado: (2009)

Chemotherapy in the Setting of Severe Liver Dysfunction in Patients with Metastatic Colorectal Cancer
por: Kasi, Pashtoon Murtaza, et al.
Publicado: (2015)

Gene expression profile predictive of response to chemotherapy in metastatic colorectal cancer
por: Estevez-Garcia, Purificacion, et al.
Publicado: (2015)

Cost-effectiveness of cetuximab and panitumumab for chemotherapy-refractory metastatic colorectal cancer
por: Carvalho, Adriana Camargo, et al.
Publicado: (2017)

Metronomic chemotherapy with capecitabine for metastatic colorectal cancer in very elderly patients
por: Jung, Yun Hwa, et al.
Publicado: (2017)

The Impact of Bevacizumab and Chemotherapy on Quality of Life in Metastatic Colorectal Cancer Patients
por: Moisuc, Diana Cornelia, et al.
Publicado: (2023)

The Impact of Palliative Chemotherapy on the Survival of Patients With Metastatic Colorectal Cancer in Jordan
por: Alkader, Mohammad S, et al.
Publicado: (2023)

Rechallenge therapy and treatment holiday: different strategies in management of metastatic colorectal cancer
por: Tonini, Giuseppe, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_kc2t54f5gut6fl223tcodgunva